Last reviewed · How we verify

Ropivacaine with epinephrine injection

Seoul National University Hospital · Phase 3 active Small molecule

Ropivacaine with epinephrine injection works by blocking nerve signals to provide local anesthesia and vasoconstriction.

Ropivacaine with epinephrine injection works by blocking nerve signals to provide local anesthesia and vasoconstriction. Used for Regional anesthesia for surgical procedures, Pain management for postoperative patients.

At a glance

Generic nameRopivacaine with epinephrine injection
Also known asHanlim ropiva injection 7.5 mg/mL (20cc), Insurance code: A37804211, Jeil epinephrine injection 1 mg/mL (1cc), Insurance code: A04900341, Naropin
SponsorSeoul National University Hospital
Drug classLocal anesthetic
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesiology
PhasePhase 3

Mechanism of action

Ropivacaine is a local anesthetic that selectively blocks sodium channels in nerve fibers, preventing the initiation and transmission of nerve impulses. The addition of epinephrine causes vasoconstriction, which prolongs the duration of anesthesia and reduces bleeding at the injection site.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: